- Telehealth Visits
- Insurance plan information
Miho Schutzenhofer, LCSW
Perinatal Mental Health • Social Work- Telehealth Visits
- Insurance plan information
Miho Schutzenhofer, LCSW
Perinatal Mental Health • Social Work- Telehealth Visits
- Insurance plan information
On this page
About me
Miho Schutzenhofer is a social worker who cares for patients who are pregnant or postpartum. She specializes in treating anxiety and depression with cognitive behavioral therapy (CBT), which helps people recognize negative thought patterns and develop coping strategies for them.
Schutzenhofer earned her master's degree in social work from New York University.
Education & training
Degree
- MSW, New York University
My expertise
Specialties
- Perinatal Mental Health
- Social Work
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%223817%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223817%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.